IFF - International Flavors & Fragrances Inc.

NYSE - NYSE Delayed Price. Currency in USD
134.88
+1.75 (+1.31%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close133.13
Open133.37
Bid134.85 x 900
Ask134.86 x 1100
Day's Range132.84 - 135.06
52 Week Range104.86 - 152.95
Volume929,362
Avg. Volume1,163,404
Market Cap14.403B
Beta (5Y Monthly)0.87
PE Ratio (TTM)39.68
EPS (TTM)3.40
Earnings DateFeb 10, 2020 - Feb 16, 2020
Forward Dividend & Yield3.00 (2.22%)
Ex-Dividend DateDec 24, 2019
1y Target Est134.85
  • Moody's

    Innophos Holdings, Inc. (New) -- Moody's assigns B2 CFR rating to Innophos Holdings, Inc.; outlook stable

    Moody's Investors Service, ("Moody's") has assigned a B2 Corporate Family Rating (CFR) and B2-PD Probability of Default Rating (PDR) to Innophos Holdings, Inc. ("Innophos"). Moody's has also assigned a B1 rating to the proposed $415 million senior secured first lien term loan and a Caa1 rating to the proposed $300 million senior unsecured notes.

  • 6 Guru Stocks With Negative Performances
    GuruFocus.com

    6 Guru Stocks With Negative Performances

    Icahn Enterprises makes the list Continue reading...

  • Reuters

    DuPont to explore divestiture of electronics unit - BBG

    Industrial materials maker DuPont is working with advisers to review strategic options, including a sale, for its electronics business, Bloomberg reported https://www.bloomberg.com/news/articles/2020-01-16/dupont-is-said-to-explore-divestiture-of-electronics-unit on Thursday, citing people familiar with the matter. The Electronics and Imaging unit, whose customers include semiconductor and LED makers, was the smallest of Dupont's core business by revenue at the end of the third quarter. The unit's revenue fell in the three quarters of 2019 reported so far, as it struggled with trade uncertainties which exasperated a cyclical weakness in the semiconductor market.

  • International Flavors & Fragrances Inc. (NYSE:IFF) Is Yielding 2.3% - But Is It A Buy?
    Simply Wall St.

    International Flavors & Fragrances Inc. (NYSE:IFF) Is Yielding 2.3% - But Is It A Buy?

    Could International Flavors & Fragrances Inc. (NYSE:IFF) be an attractive dividend share to own for the long haul...

  • 3 Big Stock Charts for Tuesday: DuPont, Exelon, and Cabot Oil & Gas
    InvestorPlace

    3 Big Stock Charts for Tuesday: DuPont, Exelon, and Cabot Oil & Gas

    Even with declines on Monday, U.S. stocks are closing out a remarkably strong 2020. The S&P 500 has gained 28.5% so far this year, and the NASDAQ Composite has performed even better. On the whole, American equities, barring a disaster on Tuesday, should post their second-best year since 1997.Source: Shutterstock As noted in the space before, the rally has been both broad and deep. Nearly 80% of stocks with a market capitalization over $300 million are positive in 2019. Almost 20% of those stocks have risen at least 50%. But that still leaves a few names that have been left out of the rally. * 6 Transportation Stocks That Are Going Places Tuesday's big stock charts focus on that group. Two of these stocks have declined so far this year, amid broad pressure on their respective industries. Another has gained less than 1%. But all three of late have shown support, which suggests at least some optimism heading into the New Year.InvestorPlace - Stock Market News, Stock Advice & Trading Tips DuPont de Nemours (DD)Source: Provided by Finviz DuPont de Nemours (NYSE:DD) has been one of the most disappointing stocks of the past few years. In a complicated feat of financial engineering, chemical giants Dow and DuPont first merged into DowDuPont. DowDuPont then spun off the 'new' Dow Inc. (NYSE:DOW) and agricultural play Corteva (NYSE:CTVA) before renaming itself DuPont de Nemours.If that wasn't enough, DuPont this month announced it would combine its nutrition unit with International Flavors & Fragrances (NYSE:IFF). Yet, as the first of Monday's big stock charts shows, none of that movement has created any shareholder value.DowDuPont was a popular pick for sum of the parts upside, but DD stock is down 18% this year (adjusted for the spins). DOW stock has gained 9% since becoming independent, while CTVA is basically flat. The question heading into 2020 is whether the stock finally can stabilize: * Technically, a double bottom around $62 does provide some hope. A Relative Strength Index of 39 isn't quite in oversold territory, but it's not far off. Monday's 2%-plus decline doesn't help the cause, but it's possible that some investors were looking to book tax losses to offset gains elsewhere. Hedge funds may also want the disappointing stock off their books at year-end. There may be buyers willing to step in. * Fundamentally, there is an attractive case here. Earlier this month, I highlighted both DD stock and IFF stock as 2019 losers that could be 2020 winners. The nutrition merger will give DuPont a cash payment of over $7 billion that can be used to pay off debt and buy back stock. And after the sell-off, DuPont stock trades at a reasonable 14.6x forward price-to-earnings multiple. * Click to Enlarge Source: Provided by Finviz But this may be a stock that still has further to fall. The weekly chart still shows a persistent downtrend. End markets remain volatile, and earnings multiples across the chemicals sector usually are below those of the market as a whole. It's possible investors are waiting for the calendar to turn to step into the decline here. But it's also possible that DuPont stock will continue to disappoint in early 2020 as well. Excelon Corporation (EXC)Utility Exelon Corporation (NYSE:EXC) has had a disappointing 2019 as well. Utilities as a sector, as measured by the Utilities Select Sector SPDR Fund (NYSE:XLU), have gained 21%. EXC stock has risen just 0.62%. There are some reasons for the underperformance -- but as the second of our big stock charts shows, investors of late have bet on an improved 2020: * A multiple bottom has been established at $44 and Excelon stock has shown some strength in the last two weeks. Shares have cleared near-term moving averages as well. Utility stocks are usually much less volatile, so a huge breakout is unlikely. But, technically, EXC has a path to the 200-day moving average above $47, and then could challenge the top of a descending triangle pattern. * There are two core worries here. Exelon is facing a federal investigation of its lobbying efforts in Illinois, a probe that may be linked to the sudden resignation of the company's chief executive officer in October. In addition, Exelon's nuclear business is waning: the company shut down its Three Mile Island reactor earlier this year. Both factors have pressured Exelon stock in recent months, and explain in part why shares have lagged the sector. * That said, there's some value here. On an earnings basis, EXC is one of the cheaper large-cap utility stocks in the market. A 3.2% dividend yield should be safe, and remains attractive in an environment where the 10-year Treasury bond yields less than 2%. Federal investigations are hardly welcome, but this is a company with a $44 billion market capitalization. Penalties relating to any untoward actions are likely to be relatively minimal in that context. There's a case that the sell-off has gone too far. Some investors are acting on that case as 2020 approaches. Cabot Oil & Gas (COG)Source: Provided by Finviz Shale exploration plays like Cabot Oil & Gas (NYSE:COG) have had a difficult 2019. Low oil and natural gas prices have hurt profits. The acquisition of Anadarko Petroleum by Occidental Petroleum (NYSE:OXY) was supposed to unleash a wave of merger activity in the sector. But OXY stock wound up hitting a 14-year low in November, potentially scaring off other buyers.Despite the sector weakness, investors have tried to time the bottom in COG stock on a few occasions in the second half of 2019. At the moment, that looks like a potentially dicey bet: * COG stock is fading again after bouncing off support at $16 earlier this month. That fade re-establishes the bearish descending triangle pattern. Near-term moving averages need to provide some help to the stock; otherwise, COG is testing $16 again, and this time around, support may not hold. * On an earnings basis, Cabot Oil & Gas stock does look somewhat cheap, at a little over 10x 2019 EPS estimates. But that multiple hardly is out of line for shale plays. Those same analysts project a roughly 25% decline in profits next year. And a core cyclical worry hangs over COG stock and much of the shale sector. If West Texas Intermediate crude prices are barely holding $60 in a booming economy, what happens when the macro picture inevitably reverses? * It's certainly possible that COG shares improve in 2020, after a 23% decline so far in 2019. That said, caution seems advised, at least in the early going. The shale boom has delivered for consumers. But whether it's explorers like Cabot or even services providers like Halliburton (NYSE:HAL), it hasn't done so yet for investors. It seems too early to believe that 2020 will be notably different.As of this writing, Vince Martin has no positions in any securities mentioned. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 6 Transportation Stocks That Are Going Places * 5 Bold Stock Market Predictions for 2020 * 3 Beer Stocks to Own Heading Into New Year 2020 The post 3 Big Stock Charts for Tuesday: DuPont, Exelon, and Cabot Oil & Gas appeared first on InvestorPlace.

  • Will DuPont (DD) Witness Turbulence in the Next Year Too?
    Zacks

    Will DuPont (DD) Witness Turbulence in the Next Year Too?

    A challenging global economic scenario and soft end-market demand due to the trade war have kept DuPont's (DD) stock under pressure.

  • Can You Imagine How International Flavors & Fragrances's (NYSE:IFF) Shareholders Feel About The 19% Share Price Increase?
    Simply Wall St.

    Can You Imagine How International Flavors & Fragrances's (NYSE:IFF) Shareholders Feel About The 19% Share Price Increase?

    It might be of some concern to shareholders to see the International Flavors & Fragrances Inc. (NYSE:IFF) share price...

  • Boeing’s Days of Being the Bully Are Over
    Bloomberg

    Boeing’s Days of Being the Bully Are Over

    (Bloomberg Opinion) -- To get Brooke Sutherland’s newsletter delivered directly to your inbox, sign up here.Boeing Co. was an aerospace industry bully for years, leveraging its position as the preeminent U.S. commercial-jet maker to squeeze its suppliers, badger its rivals with trade disputes and reportedly lobby for more oversight over the regulatory review of its own planes. Two fatal crashes and a global grounding of its best-selling 737 Max jet have upended the power dynamic. With its latest decision to halt production, Boeing’s comeuppance is complete.The company announced this week that it would completely shut down production of the Max starting in January. The decision follows a surprisingly indignant and public upbraiding by the Federal Aviation Administration over the company’s unrealistic timeline for the jet’s return and concerns that it was trying to pressure regulators to act more quickly. The Max has been grounded for nine months as regulators review a proposed software fix to a flight-control system and grapple with deeper questions about Boeing’s priorities and flaws in its oversight processes and understanding of pilot reactions. The FAA reportedly may not clear the plane until February at the earliest, and seems increasingly likely to move in tandem with more reticent international regulators rather than lead the charge on approving the Max for flight. Faced with a glut of 400 undeliverable planes, a deepening cash crunch and no clear end in sight to the grounding, the gravity of the damage Boeing has done to its reputation finally seems to be sinking in. It didn’t help matters that Boeing’s unmanned CST-100 Starliner failed to reach the International Space Station Friday. One way to read this production cut is that the company is going into self-preservation mode. While undoubtedly a drastic step, pulling the plug on production should help Boeing conserve cash in the near term as it will stop adding to inventory. But it will raise the longer-term financial cost of the Max crisis, put Boeing’s competitive position further at risk and wreak havoc on many of its suppliers. Citing these concerns, both S&P and Moody’s Investors Service lowered Boeing’s credit rating this week. Boeing in April cut 737 production to 42 planes per month, down from a pre-crash pace of 52. Many suppliers would likely have preferred to see another cut versus a complete stop because it becomes much more difficult to ramp up again if their own network of parts and service providers goes cold. Boeing reportedly believed a full-blown halt over a specific time period would offer more certainty for workers and make them less likely to jump ship in a tight labor market. The production cut it announced this week is instead open-ended. In a way, the lack of a fresh timeline shows the FAA’s effort to humble Boeing is working. But it also makes suppliers – and the broader economy – that much more exposed to the Max crisis at a time when U.S. manufacturing is still soft.Spirit AeroSystems Holdings Inc., which gets more than 50% of its revenue from 737 aircraft components, had been continuing to manufacture airframes at the 52-a-month pace throughout the grounding. Now, it, too, is fully halting production. In the understatement of the year, this suspension “will have an adverse impact on Spirit's business, financial condition, results of operations, and cash flows,” the company said in a statement Friday. Spirit shares fell about 6% this week, while fellow Max suppliers Woodward Inc. and Moog Inc. dropped about 5% and 2%, respectively. The production halt will reduce first quarter U.S. gross domestic product by about 0.5 percentage point, according to estimates from IHS Markit and JPMorgan Chase & Co.General Electric Co.’s CFM engine joint venture with Safran SA is the sole provider for the Max and will likely need to rejigger its own production plans. Perversely, that could actually boost GE’s cash flow because new engine shipments tend to be less profitable than spares or maintenance work. The situation also could allow the company to devote more resources to maintaining engines on stored jets so they can be more quickly brought back into service. Boeing’s commitment to prioritize delivering the 400-odd planes in storage over cranking out new ones should help speed associated payments to GE. Meanwhile, GE is reportedly in discussions with Airbus SE about increasing production of engines for that company's rival to the Max to help maintain its factory capacity. Longer term, however, the company’s elevated exposure to any slippage in the Max backlog or lingering reputational damage is a liability, notes JPMorgan analyst Steve Tusa, who says it’s a possibility the plane doesn’t return at all.I think those suppliers are going to remember all of this the next time they enter contract negotiations with Boeing. Before the two Max plane crashes, Boeing had been pushing for cost cuts in an effort to capture some of its suppliers’ rich profit margins for itself, and had pushed to bring more parts and services work in house through joint ventures and acquisitions. That all likely ends. In the near term, rather than negotiating with Boeing over cost, its suppliers are more likely going to be negotiating for compensation or some sort of arrangement to smooth out the hits to their business from this binary approach to production. In the long term, Boeing’s efforts to rebuild its reputation must entail a reckoning with persistent allegations that it prioritized profit over safety. How does the company do that while encouraging its suppliers to make the kind of cutbacks and outsourcing decisions that landed it in hot water?Apart from the obvious fact that Boeing won’t have cash to spare for acquisitions anytime too soon, the Max crisis should prompt regulators to question the wisdom of allowing the company to continue to consolidate more of the aerospace industry within itself. And suppliers would be justified in being more critical of these attempts to raid their market share. The Max crisis was manufactured largely by Boeing itself, rather than its supply chain. As painful as the production cut will be, the suppliers now at least have more leverage.RETURN OF THE REVERSE MORRIS TRUSTWhoever said taxes were a certainty on par with death was clearly not an M&A banker. There were at least two big Reverse Morris trust deals announced this week, with DuPont de Nemours Inc. agreeing to combine its nutrition and biosciences division with International Flavors & Fragrances Inc., and Ecolab Inc. merging its Nalco Champion oilfield chemicals unit with Apergy Corp. Reverse Morris trusts are a way for larger companies to divest assets without having to pay taxes, as they would in a direct sale. These transactions historically are somewhat rare because the two businesses have to be almost equal in size to meet the requirements, but there’s been a resurgence this decade, particularly among industrial companies, in a natural consequence of the breakup frenzy that’s gripped the sector. The IFF deal values the DuPont nutrition business at $26.2 billion and marks the latest in a long line of breakups for DuPont. The company also is reportedly contemplating a divestiture of its transportation and industrial division. But DuPont doesn’t have much to show for all its slicing and dicing to date, and its conclusion that the solution to its underperformance is yet more breakups makes me ask — yet again — if this craze is going too far. (1)The Apergy-Ecolab deal offers a counterpoint. Apergy was spun off from Dover Corp. last year, and while it’s outperformed the S&P 500 energy sector, it hasn’t been able to avoid the drag from low oil prices and a shift in priorities among exploration companies under pressure to boost shareholder returns. From the outside, Apergy looked like another example of when a spinoff has benefited the parent company much more than the unshackled business. But one argument that activist investors often make for breakups is that businesses benefit from having independent control over their capital spending decisions, which include M&A. The deal with Ecolab likely wouldn’t have happened if Apergy was still part of Dover. Ecolab had initially planned to spin off its energy business. But the combined company, which is expected to have an enterprise value of $7.4 billion, should be stronger than either would have been on their own. Its increased international exposure and well-rounded offerings across oilfield chemicals, equipment and services should help it in a world where energy investors are prioritizing scale and stable free cash flow.(2)FEDEX SPECIAL DELIVERY: CHRISTMAS COALBoeing had the worst 2019 by far among industrial companies, but FedEx Corp. comes in second on my list. The company this week reported yet another cut to a fiscal 2020 forecast that was disappointing to begin with as it continues to struggle with the challenge of ferrying the deluge of e-commerce shipments to consumers’ doorsteps. FedEx continues to blame exogenous factors for its shortcomings: a cyberattack on its TNT Express business that delayed the integration of that acquisition; the U.S.-China trade war; the quirks of the calendar this year. All of those things undoubtedly played a role in FedEx’s earnings slippage, but the real problem seems to be a management team that was unprepared to weather those shocks and has worn out investor patience with unfulfilled promises of a turnaround. Chief Financial Officer Alan Graf says FedEx is nearing a bottom. Practically speaking, that may be true but that leaves a lot of unanswered questions about how FedEx will compete in a shipping world that now includes Amazon.com Inc. as a full-blown competitor. Amazon stopped working with FedEx for its own deliveries earlier this year and this week banned third-party merchants from using the carrier for Prime deliveries because of what it said was a decline in performance. Lest there were any lingering doubts about Amazon’s delivery capabilities, the company also announced this week that its logistics arm now handles about half of deliveries and is on pace to deliver 3.5 billion of its own packages this year.DEALS, ACTIVISTS AND CORPORATE GOVERNANCELeidos Holdings Inc. this week agreed to acquire research and national-security services company Dynetics for $1.65 billion. Dynetics focuses on some of the fastest growing parts of the U.S. Defense Department’s budget, including hypersonics, space, directed energy, artificial intelligence, machine learning and micro-electronics, according to Cowen analyst Cai von Rumohr. So the deal should be a boon to Leidos’s margins and growth. This is the latest example of a defense company betting bigger is better as they jockey for positioning in the DoD budget. The strategic benefits offset a somewhat rich price. Leidos is paying roughly 15 times Dynetics expected 2020 Ebitda, but that multiple drops to 12.6 after accounting for tax benefits. Dynetics is a private, employee-owned company, which Leidos was as well before it went public, so that should help smooth the cultural integration, notes von Rumohr.FirstGroup Plc, having already committed to selling the U.S. Greyhound bus service and other assets, is expanding its breakup plan to include the North American school bus and transit divisions. FirstGroup came under pressure to shake up its business after rejecting two takeover offers from Apollo Global Management that the company said undervalued it, only to see its share price flounder amid disappointing results. The North American assets have a value of at least $5 billion, according to activist investor Coast Capital, which earlier this year sought an overhaul of the board to push through its breakup strategy. Coast Capital’s proxy fight failed, but FirstGroup Chairman Wolfhart Hauser still departed.Clariant AG agreed to sell a plastic-pigments unit to PolyOne Corp. for about $1.5 billion. The chemicals are used to color car parts and packaging, and Baader analyst Markus Mayer hadn’t expected Clariant to get that much for it amid a slump in automotive markets. The deal values the business at about 11 times its adjusted Ebitda in the past year, but expected cost savings of $60 million bring that multiple down to less than 8 times. For PolyOne, the deal continues the company’s shift toward higher-margin specialty chemicals.BONUS READING  A Major Shipping Change Is Coming, and So Are Higher Fuel Prices Truckmakers Slash Jobs by the Thousands as Orders Dry Up  Billionaire Agnellis Get to Keep Their Sweetener: Chris Bryant Foxconn Plays Tax-Credit Poker With Wisconsin: Tim Culpan Tesla, Saudi Aramco and the Stock Price Bros: Liam DenningA Third of America’s Economy Is Concentrated in Just 31 Counties(1) At least DuPont is getting well-compensated for its nutrition business, much to the chagrin of IFF investors who sent the stock down 8% on the week.(2) The value of diversification through M&A doesn’t fare so well in this example. Ecolab, primarily a provider of chemicals for water and waste-water treatment, built its oilfield services business through the acquisitions of Nalco Holding Co. for $8.1 billion (including debt) in 2011 and Champion Technologies Inc. for $2.2 billion in 2013.To contact the author of this story: Brooke Sutherland at bsutherland7@bloomberg.netTo contact the editor responsible for this story: Beth Williams at bewilliams@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Brooke Sutherland is a Bloomberg Opinion columnist covering deals and industrial companies. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.

  • Moody's

    International Flavors & Fragrances, Inc. -- Moody's affirms International Flavors and Fragrances rating at Baa3; outlook revised to negative

    Moody's Investors Service, ("Moody's") affirmed the Baa3 ratings of International Flavors and Fragrances, Inc. ("IFF") and its Prime-3 rating for commercial paper. The outlook revision follows the announcement that IFF has signed a definitive agreement to merge with the DuPont De Nemours, Inc.'s ("DuPont") Nutrition and Biosciences business for approximately $26.2 billion in cash and equity. "The negative outlook reflects the significant size of the transaction, the remaining integration risk from the Frutarom transaction and the lack of a consistent growth record at DuPont's Nutrition and Biosciences ("N&B") business, as well as credit metrics that are not reflective of the Baa3 rating" said Domenick R. Fumai, Moody's Vice President and lead analyst for IFF.

  • Barrons.com

    DuPont Has Narrowed Its Focus. Analyst Sees a Winner for 2020.

    Continued divesting has left DuPont with only the higher-margin core businesses as well as more cash for shareholder returns, Cowen analyst Charles Neivert wrote in a note.

  • Market Exclusive

    Market Morning: Green Goldman, Boeing Brought Low, Moody’s Wary of China Debt

    Goldman Sachs To Pump Money Into Green New Deal What would Alexandria Ocasio-Cortez do? Maybe something like this, if she had $750 billion to throw around. Goldman Sachs (NYSE:GS) is aiming to loan this much money to projects that fight climate change or “help financially disadvantaged people,” which could mean just about anything. Everyone who […]The post Market Morning: Green Goldman, Boeing Brought Low, Moody's Wary of China Debt appeared first on Market Exclusive.

  • Barrons.com

    Kerry Group Missed Out on the DuPont Deal. The Irish Butter Maker May Need a New Growth Plan.

    Kerry Group lost out on the $26.2 billion deal to buy DuPont’s nutrition business. CEO Edmond Scanlon has made no secret that he wants to expand Kerry’s Taste and Nutrition division.

  • IFF shares sink on expensive plant-based meat bet with Dupont
    Reuters

    IFF shares sink on expensive plant-based meat bet with Dupont

    As part of the deal, IFF will pay DuPont shareholders $7.3 billion in a special cash payment, adding to its long-term debt of roughly $4 billion. DuPont shareholders will own 55.4% of the shares of IFF, but IFF Chief Executive Officer Andreas Fibig will run the combined company and also continue to be the board chairman. The deal will bring together the nutrition and biosciences business of DuPont, which makes the protein used in plant-based patties produced by firms such as Impossible Foods and Beyond Meat , and IFF that provides flavor, seasoning and natural color for these vegan burgers.

  • Barrons.com

    The Dow Is Up 175 Points Because the Trade War News Is Sinking In

    The three major U.S. stock market indexes were solidly in the green as investors seemed to take a risk-on approach after an initial trade deal between the U.S. and China was announced last week.

  • DuPont’s Breakups Only Lead to More Breakups
    Bloomberg

    DuPont’s Breakups Only Lead to More Breakups

    (Bloomberg Opinion) -- Round and round the DuPont merry-go-round of financial engineering we go.The chemicals giant agreed on Sunday to sell its nutrition and biosciences division to International Flavors & Fragrances Inc. via a tax-friendly Reverse Morris Trust transaction that values the business at about $26 billion. DuPont de Nemours Inc. will receive a one-time $7.3 billion cash payment and its shareholders will own 55.4% of the combined entity.This is just the latest in a long line of dealmaking by DuPont chairman Ed Breen, who earned the respect of the investing world for salvaging Tyco International from scandal in part by breaking it up several times.(1) At DuPont, he’s helped orchestrate a complicated merger with rival Dow Chemical and a subsequent three-way split. After some rejiggering of the combined companies’ various assets amid pushback from activist investors, DuPont this year spun off the Dow Inc. commodity-chemical business and the Corteva Inc. agricultural-products company. Breen may not be done tinkering with DuPont’s portfolio after the International Flavors deal; Bloomberg News has reported that DuPont is also evaluating a divestiture of its transportation and industrial-chemicals unit.  The results of all this maneuvering have been just so-so. Dow is up about 9% since the March record date for its separation, lagging the S&P 500 Index and the benchmark’s materials sub-group. Corteva has slumped nearly 6% since its May debut. DuPont itself is down more than 14% so far this year. That’s partly a reflection of the sheer amount of time it took to orchestrate this complicated musical chairs.The merger with Dow was announced four years ago, and the interim waiting period can create a sort of spin purgatory as investors hold off on rewarding a soon-to-be-simpler company with a valuation lift until all the paperwork is signed. And when a process takes that long, you’re bound to become a victim of bad timing. Dow and Corteva were spun off into a terrible market for chemicals as the U.S.-China trade war and a slowing economic backdrop weighed on demand and profit margins. Moody’s Investors Service this month issued its 2020 outlook for the North American and EMEA chemical sector, calling for an average Ebitda decline of about 5% amid soft commodity prices and weak investment trends. DuPont shares, meanwhile, also have been dragged down by its legal fight with a prior spinoff, Chemours Co., over liabilities linked to PFAS, the so-called forever chemical that was used in the manufacturing of Teflon.Breakup enthusiasts would tell you the share slump might have been worse if these businesses were still bundled together and one management team was trying to oversee their competing capital requirements and growth profiles. There’s certainly a logic to this latest deal. Nutrition and biosciences is DuPont’s largest division and has one of the more attractive growth profiles, but DuPont clearly wasn’t getting credit for this business in its stock.The deal with IFF values the DuPont unit at more than 18 times its adjusted Ebitda in the past year, according to data compiled by Bloomberg. That’s well above what the parent company commands. At the same time, there’s a reason the nutrition and biosciences unit commands a higher valuation. The removal of this generally stable business may make it harder for DuPont to prove that its earnings and sales growth can rise above economic volatility.If DuPont follows through on carving out the transportation and industrial unit as well, that would help limit its exposure to the swings in the automotive industry, which has been a particularly tough market of late. But it’s unclear what the endgame is here. There’s something deeply unsatisfying about a company using yet more breakups to fix a valuation disconnect that its first round of breakups was meant to rectify. Eventually, you run out of assets to sell or spin off. (1) Tyco eventually merged with Johnson Controls years after Breen had moved on, and the combined company took the latter’s name.To contact the author of this story: Brooke Sutherland at bsutherland7@bloomberg.netTo contact the editor responsible for this story: Beth Williams at bewilliams@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Brooke Sutherland is a Bloomberg Opinion columnist covering deals and industrial companies. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.

  • DuPont merging nutrition unit in $26.2 billion deal
    American City Business Journals

    DuPont merging nutrition unit in $26.2 billion deal

    The deal is DuPont's latest in the wake of DowDuPont's break up into three different public companies

  • International Flavors (IFF) Seals Merger Deal With DuPont Arm
    Zacks

    International Flavors (IFF) Seals Merger Deal With DuPont Arm

    International Flavors' (IFF) merger deal to create a leading company in high-value ingredients and solutions for food and beverage, home and personal care, and health & wellness markets.

  • Barrons.com

    IFF Wins Race for DuPont’s Nutrition Business in $26.2 Billion Deal

    International Flavors & Fragrances (IFF) has agreed to merge with DuPont’s nutrition business to create a $45 billion consumer goods company.

  • DuPont's nutrition unit to merge with IFF
    Yahoo Finance Video

    DuPont's nutrition unit to merge with IFF

    DuPont's deal with IFF will create a new company valued at about $45 billion. Yahoo Finance’s Zack Guzman and Heidi Chung, along with Ruby Media Group President Kristen Ruby, break it down on YFi PM.

  • IFF to merge with DuPont nutrition unit
    Reuters Videos

    IFF to merge with DuPont nutrition unit

    International Flavors & Fragrances has a taste for DuPont. It's merging with DuPont's nutrition business. Together, they're creating a consumer giant that will boast revenue of $11 billion and a valuation of $45 billion. As its name implies, IFF works with global brands to develop scents and tastes for products ranging from plant-based burgers to perfumes. DuPont shareholders will own a 55% stake in the new company, leaving IFF shareholders with 45%. The combined company expects to save $300 million in costs by the end of the third year. IFF shares fell more than 7% in early trading Monday. DuPont shares rose modestly.

  • DuPont–IFF deal creates company valued around $45B
    Yahoo Finance Video

    DuPont–IFF deal creates company valued around $45B

    DuPont is selling its food science unit to International Flavors & Fragrances for $26 billion. The deal will create a new consumer giant worth more than $45 billion dollars.